Medidata secures new enterprise agreements with several customers

Medidata has seen significant momentum and reaffirmed its vision to progress the life sciences industry forward, securing new enterprise agreements with several large customers, a strengthened industry partnership in central nervous system, a strengthened presence in digital therapeutics, and expanded leadership. Medidata further solidified its market leadership to transform life sciences through its focus on innovative, AI-powered solutions and strengthened approach on Patient, Data, and Study Experiences, extending the brand’s impact beyond clinical trials through commercialization and the delivery of more accessible, effective therapies to patients. “Medidata continues to drive innovation across the life sciences ecosystem,” said Anthony Costello, CEO, Medidata. “We’ve received significant industry recognition for Medidata Clinical Data Studio, an integral offering within our Data Experience, as well as our partnerships with Click Therapeutics and Cogstate, which are generating strong interest with customers. These bold moves will deliver new solutions for patients, sites, and sponsors and represent concrete steps towards improving outcomes and advancing healthcare.”